12 month follow-up of mebendazole therapy for onchocerciasis.
D001562:Benzimidazoles / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008463:Mebendazole / Q000627:therapeutic use*; D009855:Onchocerciasis / Q000188:drug therapy*; D011897:Random Allocation; D013997:Time Factors
D001562:Benzimidazoles; D008463:Mebendazole